Transcendent Capital Group’s Inspire Corporate Bond ETF IBD Stock Holding History
Bought
Maintained
Sold
Other funds holding IBD
IA
FA
CIA
CFD
CW
BFS
II
OFS
PFG
OWM
Transcendent Capital Group's IBD Position: Q1 2025 in Review
Transcendent Capital Group sold out of Inspire Corporate Bond ETF (IBD) in Q1 2025, closing a stake of 1,638 shares — an estimated $38.4K sold.
Transcendent Capital Group first reported a position in IBD in Q3 2024 and held it in 2 quarters. The position peaked at $38.4K in Q4 2024. 92 funds tracked by Wall St. Rank hold IBD as of Q1 2025.
- Transcendent Capital Group reported no remaining Inspire Corporate Bond ETF position as of Q1 2025 after selling out during the quarter.
- Transcendent Capital Group sold 1,638 Inspire Corporate Bond ETF shares in Q1 2025, an estimated $38.4K.
- Transcendent Capital Group first reported a position in Inspire Corporate Bond ETF in Q3 2024 and held it in 2 quarters.
- Transcendent Capital Group's Inspire Corporate Bond ETF position peaked at $38.4K in Q4 2024.
- 92 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q1 2025.
Based on Transcendent Capital Group's 13F filing for Q1 2025, filed 2 May 2025.